Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.6.2409

Utility of Peripheral Blood Parameters in Predicting Breast Cancer Risk  

Okuturlar, Yildiz (Internal Medicine, Bakirkoy Dr. Sadi Konuk Training and Research Hospital)
Gunaldi, Meral (Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital)
Tiken, Elif Eda (Radiation Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital)
Oztosun, Bugra (Internal Medicine, Bakirkoy Dr. Sadi Konuk Training and Research Hospital)
Inan, Yesim Ozdem (Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital)
Ercan, Tarik (Internal Medicine, Bakirkoy Dr. Sadi Konuk Training and Research Hospital)
Tuna, Savas (Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital)
Kaya, Ali Osman (Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital)
Harmankaya, Ozlem (Internal Medicine, Bakirkoy Dr. Sadi Konuk Training and Research Hospital)
Kumbasar, Abdulbaki (Internal Medicine, Bakirkoy Dr. Sadi Konuk Training and Research Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.6, 2015 , pp. 2409-2412 More about this Journal
Abstract
Purpose: We aimed to study the inflammatory parameters of complete blood count in breast cancer cases. Materials and Methods: This retrospective study covered 178 breast cancer patients and 107 age and body mass index matched healthy women. Complete blood count parameters, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and MPV/platelet were analyzed. Results: The leukocyte, neutrophil and neutrophil/lymphocyte ratio were higher in the patient group (p values 0.001, 0.0001 and 0.0001, respectively) while haemoglobin and hematocrit were higher in the control group (p=0.0001 for both). Logistic regression analysis showed that elevated neutrophils and platelet distribution width (PDW) (OR: 0.627, 95%CI: 0.508-0.774, p=0.001 and OR: 1.191 95%CI: 1.057-1.342 p=0.003) were independent variables for predicting breast cancer. The cut-off value for the neutrophil/lymphocyte ratio was 2.56. Conclusions: According to our study results, neutrophil levels as part of complete blood count may be used as an independent predictor of breast cancer risk.
Keywords
Breast cancer; complete blood count; neutrophils; platelet distribution width;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Aggarwal BB, Gehlot P (2009). Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol, 9, 351-69.   DOI
2 Aliustaoglu M, Bilici A, Ustaalioglu BB, et al (2010). The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol, 27, 1060-5.   DOI   ScienceOn
3 Bae SI, Kim YS (2014). Colon cancer screening and surveillance in inflammatory bowel disease. Clin Endosc, 47, 509-15.   DOI
4 Balkwill F, Mantovani A (2001). Inflammation and cancer: back to Virchow? Lancet, 357, 539-45.   DOI
5 Cho DS, Kim SJ, Lee SH, et al (2011). Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma. Korean J Urol, 52, 104-9.   DOI
6 Chua W, Charles KA, Baracos VE, et al (2011). Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer, 104, 1288-95.   DOI   ScienceOn
7 Edge SB, Compton CC (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17, 1471-4.   DOI
8 Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al (2011). Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des, 17, 47-58.   DOI
9 Gnerlich JL, Deshpande AD, Jeffe DB, et al (2009). Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am College Surg, 208, 341-7.   DOI   ScienceOn
10 Hoshida Y, Fuchs BC, Bardeesy N, et al (2014). Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. J Hepatol, 61, 79-90.   DOI
11 Hussein MR, Ahmed RA (2005). Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pre-tumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin. Cancer Biol Ther, 4, 819-21.   DOI
12 Hwang SG, Kim KM, Cheong JH, et al (2012). Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer. Eur J Surg Oncol, 38, 562-7.   DOI
13 Islam T, Dahlui M, Majid H, et al (2014). Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health, 14, 8.   DOI
14 Lee M, Kim SW, Nam EJ, et al (2011). The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer. Gynecol Oncol, 122, 238-41.   DOI
15 Lee SK, Lee SC, Park JW, et al (2014). The utility of the preoperative neutrophil-to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study. BMC Surg, 14, 100.   DOI
16 Li F-X, Wei L-J, Zhang H, et al (2014a). Significance of Thrombocytosis in Clinicopathologic Characteristics and Prognosis of Gastric Cancer. Asian Pac J Cancer Prev, 15, 6511-7.   DOI
17 Okada F (2014). Inflammation-related carcinogenesis: current findings in epidemiological trends, causes and mechanisms. Yonago Acta Med, 57, 65-72.
18 Li Y, Wei S, Wang J, et al (2014b). Analysis of the factors associated with abnormal coagulation and prognosisin patients with non-small cell lung cancer. Zhongguo Fei Ai Za Zhi, 17, 789-96 (in Chinese).
19 Majeed W, Aslam B, Javed I, et al (2014). Breast cancer: major risk factors and recent developments in treatment. Asian Pac J Cancer Prev, 15, 3353-8.   DOI
20 Mitsunaga A, Tagata T, Hamano T, et al (2014). Metachronous early gastric cancer over a period of 13 years after eradication of Helicobacter pylori. Clin J Gastroenterol, 7, 490-5.   DOI
21 Pierce BL, Ballard-Barbash R, Bernstein L, et al (2009). Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol, 27, 3437-44.   DOI   ScienceOn
22 Sicking I, Edlund K, Wesbuer E, et al (2014). Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients. PLoS One, 9, 111306.   DOI
23 Siegel R, Naishadham D, Jemal A (2012). Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin, 62, 283-98.   DOI   ScienceOn
24 Teramukai S, Kitano T, Kishida Y, et al (2009). Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer, 45, 1950-8.   DOI   ScienceOn
25 Thavaramara T, Phaloprakarn C, Tangjitgamol S, et al (2011). Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. J Med Assoc Thai, 94, 871-7.
26 Yilmaz H, Ucan B, Sayki M, et al (2014). Usefulness of the neutrophil-to-lymphocyte ratio to prediction of type 2 diabetes mellitus in morbid obesity. Diabetes Metab Syndr, (in Press).
27 Ufelle SA, Ukaejiofo EO, Neboh EE, et al (2012). Some haematological parameters in pre- and post-surgery breast cancer patients in enugu, nigeria. Int J Current Biological Medical Sci, 2, 188-90.
28 Unal D, Eroglu C, Kurtul N, et al (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42.   DOI   ScienceOn
29 Yildirim M, Suren D, Goktas S, et al (2012). The predictive role of Bcl-2 expression in operable locally advanced or metastatic gastric carcinoma. J BUON, 17, 106-9.